India COVID-19 Crowdsourced Patient Database: Vaccine Doses Administered by State
GHDx Entry last modified on: Nov 15, 2022
Disease outbreaks
Dataset Records for Disease outbreaks
Displaying 51 - 100 of 1018
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.351 2021
GHDx Entry last modified on: Jun 14, 2023
Peru Demographic and Family Health Survey 2021
Encuesta Demográfica y de Salud Familiar (ENDES) 2021
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.525 2021
GHDx Entry last modified on: Jun 14, 2023
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before a National Lockdown, March-April 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Three-month Clinical Status of A Cohort of Adult Hospitalized COVID-19 Pimpaka Srisiriwanna M.D., Poolsuk Janepanish Visudtibhan Ph.D., Kumthorn Malathum M.D
GHDx Entry last modified on: Mar 22, 2024
Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants
GHDx Entry last modified on: Mar 22, 2024
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: P.1 2021
GHDx Entry last modified on: Jun 14, 2023
Zimbabwe COVID-19 Daily Update 2021
GHDx Entry last modified on: Dec 22, 2022
Identification of spectrum of persistent post-COVID-19 symptoms and their duration in Central India: A pilot study
GHDx Entry last modified on: Mar 22, 2024
Incidence and Characterization of Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors to Recognize Syndemic Connotations in India: Single-Center Prospective Observational Cohort Study
GHDx Entry last modified on: Mar 22, 2024
United States COVID-19 Data Tracker Vaccinations 2021-2022
CDC COVID Data Tracker
Administrative data:
Epi surveillance
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint
GHDx Entry last modified on: May 12, 2022
COVID-19 Vaccination and Case Trends by Age Group, United States 2020-2022
Archive: COVID-19 Vaccination and Case Trends by Age Group, United States
Administrative data:
Epi surveillance
WHO Pulse Survey on Continuity of Essential Health Services During the COVID-19 Pandemic 2020-2021 - Round 2
GHDx Entry last modified on: Aug 4, 2023
Mongolia Multiple Indicator Cluster Survey Plus 2020-2021, Wave 2 2020
Mongolia MICS Plus 2020 Wave 2
Survey:
Household - Individual - Interview - Longitudinal - Nationally representative - Urban-rural representative
Covid-19 Vaccination Strategy In Spain 2020-2022
Estrategia De Vacunación Covid-19 En Espana
Italy Open Data on COVID-19 Vaccines 2020-2022
covid19-opendata-vaccini, Open Data su consegna e somministrazione dei vaccini anti COVID-19 in Italia
Australia Household Impacts of Covid-19 Survey November 2020
Survey:
Longitudinal
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint
GHDx Entry last modified on: May 12, 2022
Canada - British Columbia COVID-19 Situation Report 2020-2022
British Columbia (BC) COVID-19 Situation Report
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint
GHDx Entry last modified on: May 12, 2022
Colombia COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual
Malawi COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares -
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020
Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER)
Survey:
Epi surveillance
South Africa COVID-19 Special Public Health Surveillance Bulletin, Volume 18 Supplementary Issue 9, 12 March 2021
COVID-19 Special Public Health Surveillance Bulletin Volume 18 (Issue 9: 12 Mar 2021)
Epi surveillance:
Cross-sectional - Individual
33.98% of Tripura has COVID-19 antibody in them, shows sero survey
Survey:
Epi surveillance
South Africa COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Individual - Interview
Mozambique COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1
ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION
Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II
Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase
Survey:
Individual - Interview
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2020, Phase 4 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4
Bhutan Royal Centre for Disease Control Quarterly Disease Surveillance Bulletin: Fourth Quarter, October-December 2020
RCDC Surveillance Bullletin, Volume 24, 4th Quarter 2020 (1st Quarter to 30 December) 2020
Epi surveillance:
Subnationally representative
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October
GHDx Entry last modified on: May 12, 2022
Uganda COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
India - Haryana Covid-19 Sero Survey Round 2, October 2020
Sero-prevalence of Anti-SARS-CoV-2 IgG antibodies in Haryana, India: A Population based Cross-Sectional Study (2nd Round)
Survey:
Cross-sectional - Epi surveillance - Urban-rural representative
Mali COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
C''garh: 5.5 pc people have COVID-19 antibodies, says sero survey
Survey:
Cross-sectional - Epi surveillance - Individual
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany – a cross sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
India - Jharkhand Regional Outreach Bureau Twitter Communications and COVID-19 Updates 2020-2021
GHDx Entry last modified on: Aug 25, 2023
Canada COVID-19 Seroprevalence in Ontario: September 3 to October 30, 2020
GHDx Entry last modified on: May 12, 2022
Andhra Pradesh Sero Survey Show Nearly 20% of State’s Population Exposed to Covid-19
Survey:
Cross-sectional - Epi surveillance - Urban only
Sweden - Uppsala First Wave COVID-19 ICU Patient Cohort Admitted Mar-Aug 2020, 3-6 Month Follow-up Sept-Nov 2020
Survey:
Health facility - Individual - Interview - Longitudinal
Chile COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual
20% of Andhra Exposed to Covid, Sero-survey Finds, Exposure Highest Where Case Tally Lowest
Survey:
Cross-sectional - Epi surveillance - Urban only
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint
GHDx Entry last modified on: May 12, 2022
Subscribe